Fresenius SE KGaA (XSWX:FRE) Other Long-Term Liabilities: CHF1,736 Mil (As of Mar. 2026)


XSWX:FRE Fresenius SE & Co KGaA XSWX:FRE
71 GF Score
Price CHF37.79
GF Value CHF32.58
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Other Long-Term Liabilities?

Fresenius SE KGaA XSWX:FRE 71 Other Long-Term Liabilities is CHF1,736 Mil as of Mar. 2026. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF32.58 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Fresenius SE KGaA's other long-term liabilities for the quarter that ended in Mar. 2026 was CHF1,736 Mil.

Fresenius SE KGaA's quarterly other long-term liabilities declined from Sep. 2025 (CHF1,795 Mil) to Dec. 2025 (CHF1,625 Mil) but then increased from Dec. 2025 (CHF1,625 Mil) to Mar. 2026 (CHF1,736 Mil).

Fresenius SE KGaA's annual other long-term liabilities increased from Dec. 2023 (CHF1,989 Mil) to Dec. 2024 (CHF2,299 Mil) but then declined from Dec. 2024 (CHF2,299 Mil) to Dec. 2025 (CHF1,625 Mil).

Fresenius SE KGaA Other Long-Term Liabilities Related Terms

Fresenius SE KGaA Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Fresenius SE KGaA's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius SE KGaA Other Long-Term Liabilities Chart

Fresenius SE KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,123.07 4,152.73 1,988.95 2,299.49 1,624.59

Fresenius SE KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,445.42 2,418.97 1,794.96 1,624.59 1,735.70
XSWX:FRE
71GF Score
Fresenius SE & Co KGaA XSWX:FRE
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius SE KGaA Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of CHF1,736 Mil mean?
Fresenius SE KGaA (XSWX:FRE) has a Other Long-Term Liabilities of CHF1,736 Mil as of Mar. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Fresenius SE KGaA and its competitors.
Is Fresenius SE KGaA's Other Long-Term Liabilities too high?
Fresenius SE KGaA's current Other Long-Term Liabilities is CHF1,736 Mil. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Other Long-Term Liabilities compare to HCA and THC?
Fresenius SE KGaA's Other Long-Term Liabilities of CHF1,736 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Healthcare Providers & Services company?
A good Other Long-Term Liabilities depends on the Healthcare Providers & Services industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Fresenius SE KGaA and its competitors. Fresenius SE KGaA's current Other Long-Term Liabilities is CHF1,736 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF32.58, compared to a current price of CHF37.79 — trading 16% above its estimated fair value. The current Other Long-Term Liabilities is CHF1,736 Mil. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Other Long-Term Liabilities is CHF1,736 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of CHF37.79 is trading 16% above its estimated GF Value™ of CHF32.58. GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.

Key valuation signals for XSWX:FRE:

  • Other Long-Term Liabilities: CHF1,736 Mil
  • GF Value™: CHF32.58 vs. price of CHF37.79 (16% above fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score

Get the complete analysis for XSWX:FRE

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF37.79
Price
CHF32.58
GF Value